Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -3.78% vs 13.93% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -18.58% vs -38.64% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -553.57% vs -219.15% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -1.19% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Fujian Cosunter Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -3.78% vs 13.93% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -1.02% vs 5.77% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -18.58% vs -38.64% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -28.99% vs 7.39% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -553.57% vs -219.15% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -3,227.27% vs 83.08% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -1.19% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -4.60% vs -6.45% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






